共查询到20条相似文献,搜索用时 62 毫秒
1.
15年来,安徽省肿瘤防治工作取得相当进展:完成了1990年~1992年以癌症为主要内容的全省1/10人口全死因回顾调查,其结果可代表安徽省90年代初肿瘤死亡情况;肿瘤防治队伍有了长足发展,肿瘤诊治及科研水平有较大提高.用于肿瘤诊治的医疗设备不仅能基本与国内外同步,而且在市级及以上医院得到普及;开发和生产了一批抗肿瘤药。在未来的5至10年中,安徽省尚需要在以下方面作出努力:加大贯彻肿瘤诊冶规范的力度,努力提高肿瘤专业医师的水平.合理使用医疗资源并逐步完善肿瘤三级防治网,肿瘤科研争取有新的突破。 相似文献
2.
安徽省肿瘤防治办公室、安徽省抗癌协会、安徽省卫生厅医政处于1996年11月25日—29日在安徽医科大学联合举办了首届《中国恶性肿瘤诊治规范》培训班。培训班主要介绍我国肿瘤诊治工作规范要求及开展情况,几种常见癌症的诊治规范,肿瘤影像学诊断,肿瘤免疫组化及基因诊断等。培训班采用卫生部全国肿瘤防治研究办公室编写的(中国常见恶性肿瘤诊治规范)为教材,由省内各学科专家教授讲课。并作为医学继续教育的一项内容。来自全省地市级以上医院的有关专业人员参加了学习。安徽省举办《中国恶性肿瘤诊治规范》培训班@汪义高 相似文献
3.
肿瘤发病率和死亡率的高低与一个国家或地区的肿瘤诊治水平有着明显的联系。在我国尤其是边远地区和基层医疗单位,由于肿瘤专业技术人才、诊疗设备条件有限,肿瘤的误诊、漏诊、延诊及非规范化治疗现象较为普遍,从而影响了我国肿瘤防治水平。 相似文献
4.
抚顺市有城市人口220万,是煤油电钢铅生产的重工业基地,城市污染比较严重,是辽宁省肿瘤高发地区。为全面贯彻卫生部“关于进一步加强全国肿瘤防治工作的通知”和《中国常见恶性肿瘤诊治规范》,提高恶性肿瘤的诊治水平,提高治愈率和五年生存率,改善恶性肿瘤患者生存质量,抚顺市肿瘤防治办公室、市肿瘤防治院对抚顺市肿瘤规范化诊治情况进行了调查。在调查的基础上,为市卫生局提出了抚顺地区贯彻《中国常见恶性肿瘤诊治规范》的实施意见及办法。本文就抚顺地区肿瘤规范化诊治的状况和我们采取的对策作如下阐述:一、抚顺地区肿瘤规范… 相似文献
5.
恶性肿瘤是严重危害人们生命健康的疾病之一,大量的统计资料表明恶性肿瘤已成为人类致死的第1或第2位原因。为了适应肿瘤医疗市场的需要,SO年代江西省肿瘤医院由综合性医院改编成肿瘤专科医院。随着时间的推移,该院诊治肿瘤疾患的水平有了提高,医院投资了巨额经费添置了专门用于肿瘤检查及治疗的设备,但近5年来该院收治病人却呈逐年下降趋势,这种现象与专科医院的功能和任务极不相称,也使癌症的疗效在低水平徘徊。为了更好地为癌症病人诊治、提高诊治水平,有必要规范肿瘤医疗市场。一、现状笔者观察了该院近5年的六大医疗指标,发… 相似文献
6.
安徽省铜陵市地处九华山麓,长江南岸.市辖人口80万,医疗辐射人口200万。城市人口五年(1987年一1991年)死因回顾调查,肿瘤死亡居第一位,占3O13%。由于肿瘤防治事业队伍不强,缺乏必要的设备,每年1000余例肿瘤病人转院至外地。地市社区如何建立肿瘤防治网络?作为肿瘤防治工作的龙头——地市级肿瘤医院“定位”于何处?我们认为基本上有三种模式:第一种是建立起独立的地市级肿瘤医院,但投资大、建设周期长,尤其是当前我国地市财力困难,医疗投入少,专业技术人员人心不稳,床位使用率低,而办肿瘤医院,CT、B超及放疗设备都是必… 相似文献
7.
8.
卫生部委托全国肿瘤防治研究办公室会同中国抗癌协会共同组织撰写出版的我国第一部《中国常见恶性肿瘤诊治规范》(下称《规范》)已于1990年正式与广大读者见面。这是国内近50个单位,100多位肿瘤专家临床经验的荟萃和编辑人员的劳动结晶。它将成为提高肿瘤专业人员及广大医务工作者的医疗水平,指导临床实践的重要参考资料,对统一我国常见恶性肿瘤的临床分期、诊治方法以及疗效评价标准起到积极的作用。为此,应在全国范围内组织学习,认真执行。 相似文献
9.
10.
11.
《Asian Pacific journal of cancer prevention》2013,14(3):1661-1664
Recently there have been numerous advances in understanding the genetic basis of cancer which have resultedin more appropriate treatments. In this paper we describe the experience of the Burzynski Clinic, involved intreatment of numerous patients based on personalized approach using novel combinations for difficult-to-treatmalignancies, with gynecological cancers. This retrospective study was conducted by extracting data fromBurzynski Clinic’s medical records and comprehensive review. Among the advanced refractory ovarian cancerscases (N=33), an objective response (OR) was found in 42.4%. We anticipate that with improved technology andnovel therapeutics this rate will increase and adverse events will be reduced. 相似文献
12.
13.
Gene expression arrays have shown that breast cancer is comprised of at least four different molecular diseases. These are
1) basal-like breast cancer, 2) human epidermal growth factor receptor 2 (Her2)-positive/estrogen receptor (ER)-negative breast
cancer; 3) luminal A breast cancer; and 4) luminal breast B cancer. Basal-like cancer is characterized by ER-negative, progesterone
receptor–negative, and Her2-negative expressions. Luminal breast cancer is characterized by ER-positive expression, with the
luminal B subtype exhibiting a higher expression of proliferation genes. Several studies have shown that luminal A breast
cancer exhibits a better outcome compared with other classes. Also, recent studies have shown that the same subclass is less
chemosensitive. These data suggest that some selected luminal A breast cancer cases could be spared adjuvant chemotherapy
given their better outcome and lesser chemosensitivity compared with other subtypes of breast cancer. Although other subtypes
are more chemosensitive, there is debate about whether some drugs could be active in specific subtypes. Anthracyclines have
been reported to be more effective in Her2-overexpressing breast cancer, and cisplatin is currently under investigation in
basal-like breast cancer. Finally, some data suggest that luminal B breast cancer exhibits higher sensitivity to aromatase
inhibitors. Overall, molecular classes exhibit different sensitivity to conventional drugs. To what extent these data obtained
in retrospective biomarker studies could be implemented in daily practice is a matter of debate given the heterogeneity of
findings in different studies. 相似文献
14.
15.
16.
17.
Health is the first wealth of a nation, said Senator Warren Magnusen in a 1975 speech rededicating the Clinical Center at the National Institutes of Health (1). The Center, which is the largest hospital in the world devoted solely to medical research, has since been renamed the Warren Magnusen Center for Clinical Research in recognition of the Senator's support of biomedical research throughout his 46 years in the Senate. While many would agree with Senator Magnusen's statement, the national commitment to its underlying principles has clearly diminished in the intervening years. As the health needs of America have become more pressing, promising avenues of research have gone unexplored because of a lack of resources. 相似文献
18.
19.
Despite advances in treatment modalities, colorectal cancer (CRC) still accounts for about half a million deaths yearly worldwide. The majority of metastatic CRC are unresectable, and of those who undergo resection, few are cured. Advances in chemotherapy and targeted therapy have improved survival, but options remain limited, making the case for incorporating novel modalities in CRC treatment paradigm. Our improved understanding of the tumor immune microenvironment had led to the development of novel immunotherapeutic agents that have been tested in clinical trials such as cancer vaccines. Cancer vaccines are designed to activate the effector immune cells in order to generate an immune response against tumors. Dendritic cell vaccines offer potential benefits for CRC patients but requires further evaluation. We reviewed the role of dendritic cells in the colorectal tumor microenvironment and dendritic cancer vaccine studies in colorectal cancer. 相似文献
20.
Kakizoe T 《Gan to kagaku ryoho. Cancer & chemotherapy》2008,35(3):382-385
Based on the National Cancer Act, the Council for National Cancer Strategy was inaugurated and compiled the Basic Plans for National Cancer Strategy. Japan's cancer control will be promoted in accordance with the said laws hereafter. Japan's cancer control marked its 1st year and entered a very important phase. The next several years will be extremely important periods for Japan. 相似文献